Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination estrogen and progestogen replacement therapy does not adversely affect coagulation.

M Notelovitz, C Kitchens, M Ware

    Obstetrics and Gynecology
    |November 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Corrigendum to "Effectiveness of aerobic exercise training in cardiac rehabilitation: Are the metrics used so far reliable enough?" [Int J Cardiol 2024 Nov 1:414:132401].

    International journal of cardiology·2024
    Same author

    Effectiveness of aerobic exercise training in cardiac rehabilitation: Are the metrics used so far reliable enough?

    International journal of cardiology·2024
    Same author

    The diagnostic accuracy of truncated cardiovascular MR protocols for detecting non-ischemic cardiomyopathies.

    The international journal of cardiovascular imaging·2021
    Same author

    Bootstrapping quantum process tomography via a perturbative ansatz.

    Nature communications·2020
    Same author

    Experiences of using the toll-free telephone line to access maternal and newborn health services in central Uganda: a qualitative study.

    Public health·2019
    Same author

    Carboxypeptidase E (CPE) inhibits the secretion and activity of Wnt3a.

    Oncogene·2016

    Conjugated estrogens and medroxyprogesterone acetate hormone therapy did not affect coagulation in postmenopausal women. However, it enhanced fibrinolysis, indicating a safe combined regimen for healthy women.

    Area of Science:

    • Endocrinology
    • Hematology
    • Reproductive Medicine

    Background:

    • Menopause is associated with hormonal changes.
    • Hormone therapy is used to manage menopausal symptoms.
    • The impact of hormone therapy on coagulation and fibrinolysis requires investigation.

    Purpose of the Study:

    • To evaluate the effects of combined conjugated estrogens and medroxyprogesterone acetate on coagulation and fibrinolysis.
    • To compare coagulation and fibrinolysis profiles in hormone-treated menopausal women versus controls.

    Main Methods:

    • Assessed coagulation cascade dynamics, intravascular coagulation, and anticoagulation.
    • Measured prothrombin times, activated partial thromboplastin times, thrombin times, platelet counts, fibrinogen, fibrin degradation products, and natural coagulation inhibitors.

    Related Experiment Videos

  • Evaluated plasminogen antigen and activity.

    • Main Results:

    • Hormone therapy did not alter prothrombin times, activated partial thromboplastin times, or thrombin times.
    • No evidence of intravascular coagulation was observed.
    • Natural coagulation inhibitors (Antithrombin III, alpha 1-antitrypsin, alpha 2-macroglobulin) remained unaffected.
    • Plasminogen activity was enhanced, suggesting increased fibrinolysis.

    Conclusions:

    • Combined conjugated estrogens and medroxyprogesterone acetate therapy does not negatively impact the coagulation system in healthy postmenopausal women.
    • The observed enhancement in fibrinolysis suggests a potential benefit.
    • This hormone therapy regimen appears safe concerning coagulation and fibrinolysis in healthy women.